Enovis Corp. (ENOV)
22.59
+0.80
(+3.67%)
USD |
NYSE |
Feb 06, 16:00
22.59
0.00 (0.00%)
Pre-Market: 20:00
Enovis SG&A Expense (TTM) : 1.057B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Repligen Corp. | 276.62M |
| Twist Bioscience Corp. | 260.54M |
| Abbott Laboratories | 12.33B |
| Accuray, Inc. | 88.55M |
| Plus Therapeutics, Inc. | 11.09M |